Yang S - Search Results

1

Positive Correlation of Peripheral CD8⁺ T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Wu K, Xia B, Zhang J, Li X, Yang S, Zhang M, Zhu L, Wang B, Xu X, Ma S, Chen X. Wu K, et al. Among authors: yang s. Cancers (Basel). 2022 Jul 22;14(15):3568. doi: 10.3390/cancers14153568. Cancers (Basel). 2022. PMID: 35892826 Free PMC article.

2

Rechallenge with gefitinib following severe drug-induced hepatotoxicity in a patient with advanced non-small cell lung cancer: A case report and literature review.

Chen X, Pan Y, Zhang S, Chen D, Yang S, Li X, Ma S. Chen X, et al. Among authors: yang s. Oncol Lett. 2014 Mar;7(3):878-880. doi: 10.3892/ol.2013.1756. Epub 2013 Dec 11. Oncol Lett. 2014. PMID: 24527096 Free PMC article.

3

[Drug induced hepatotoxicity in targeted therapy for lung cancer].

Chen X, Yang S, Ma S. Chen X, et al. Among authors: yang s. Zhongguo Fei Ai Za Zhi. 2014 Sep 20;17(9):685-8. doi: 10.3779/j.issn.1009-3419.2014.09.08. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25248711 Free PMC article. Review. Chinese.

4

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients.

Chen X, Chen D, Yang S, Ma R, Pan Y, Li X, Ma S. Chen X, et al. Among authors: yang s. Cancer Cell Int. 2015 Apr 19;15:43. doi: 10.1186/s12935-015-0191-3. eCollection 2015. Cancer Cell Int. 2015. PMID: 25960692 Free PMC article.

5

Proteins associated with EGFR-TKIs resistance in patients with non-small cell lung cancer revealed by mass spectrometry.

Yang S, Chen X, Pan Y, Yu J, Li X, Ma S. Yang S, et al. Mol Med Rep. 2016 Nov;14(5):4823-4829. doi: 10.3892/mmr.2016.5823. Epub 2016 Oct 11. Mol Med Rep. 2016. PMID: 27748866

6

Mitochondrial pathway-mediated apoptosis is associated with erlotinib-induced cytotoxicity in hepatic cells.

Chen X, Yang S, Pan Y, Li X, Ma S. Chen X, et al. Among authors: yang s. Oncol Lett. 2018 Jan;15(1):783-788. doi: 10.3892/ol.2017.7359. Epub 2017 Nov 8. Oncol Lett. 2018. PMID: 29387241 Free PMC article.

7

Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer.

Li X, Yang S, Zhang M, Xie S, Xie Z. Li X, et al. Among authors: yang s. Eur J Histochem. 2019 Dec 11;63(4):3067. doi: 10.4081/ejh.2019.3067. Eur J Histochem. 2019. PMID: 31833327 Free PMC article.

8

A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer.

Wu K, Zhu L, Wang J, Pan K, Wang B, Li X, Yang S, Xu X, Zhang M, Li X, Chen X, Ma S, Xia B. Wu K, et al. Among authors: yang s. J Thorac Dis. 2019 Nov;11(11):4529-4537. doi: 10.21037/jtd.2019.10.81. J Thorac Dis. 2019. PMID: 31903241 Free PMC article.

9

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study.

Li X, Huang J, Qiu Y, Zhang Q, Yang S, Wu K, Wang J, Wang L, Ye J, Ma S, Xia B, Chen X. Li X, et al. Among authors: yang s. Front Pharmacol. 2021 May 7;12:649222. doi: 10.3389/fphar.2021.649222. eCollection 2021. Front Pharmacol. 2021. PMID: 34025415 Free PMC article.

10

Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient.

Yang S, Wu L, Li X, Huang J, Zhong J, Chen X. Yang S, et al. Mol Clin Oncol. 2018 Mar;8(3):457-459. doi: 10.3892/mco.2018.1553. Epub 2018 Jan 11. Mol Clin Oncol. 2018. PMID: 29456853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,574 results

Search Page

Filters